The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

Originally developed to treat type 2 diabetes and medical obesity, GLP-1 receptor agonists like tirzepatide and semaglutide ...

Wegovy, a brand name for semaglutide, is a GLP-1 inhibitor medication that targets the parts of the brain that regulate ...

“The results we got were as good as we can possibly achieve with an oral small molecule GLP-1," says Dr. Dan Skovronsky, ...

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in a late-stage study, less than previous trial results for Novo Nordisk's ...

It's the miracle drug known to curb appetite, stimulate weight loss and even help kick unhealthy addictions like smoking. But a new side effect has stumped doctors.

People taking the new wonder drug orforglipron lost an average of 12.4 per cent of their body weight after 72 weeks and ...

You might have seen people talking about a 'golden dose' on social media in regards to weight loss jabs, but what exactly is ...

While the injections from Lilly and Novo have revolutionized the way obesity is treated, investors say pills are key to ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

A woman arrested in Flagler County is accused of posing as a nurse for 18 months and seeing more than 4,000 patients before ...

A daily oral GLP-1 pill can help people with obesity lose about 12% of their body weight, according to early data shared by drugmaker Eli Lilly today. The medication, called orforglipron, may be a ...